20245 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#1202MATRIX-EMBEDDED COMPOSITIONS HAVING ORGANIC ACIDS AND FATTY ACIDS
#1203Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
#1204Pharmaceutical compositions of short-acting sedative hypnotic agent
#1205Cranberry seed oil extract and compositions containing components thereof
#1206ANTIINFECTIVE FREE INTRAMAMMARY VETERINARY COMPOSITION
#1207Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#1208Fatty acid treatment for cardiac patients
#1209TRANSDERMAL RICINOLEIC ACID COMPOSITIONS
#1210Fatty acid analogues for equilibrating bone mineral density
#1211ALPHA-LACTALBUMIN COMPOSITION
#1212Solid oral dosage form containing an enhancer
#1213COMBINATION THERAPY FOR MODULATION OF ACTIVITY AND DEVELOPMENT OF CELLS AND TISSUES
#1214COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#1215Compositions containing high omega-3 and low saturated fatty acid levels
#1216REDUCTION OF HAIR GROWTH
#1217Drug delivery medical device
#1218Statin and omega-3 fatty acids for reduction of Apo-B levels
#1219TOPICAL GEL COMPOSITION COMPRISING AZELAIC ACID
#1220Pharmaceutical formulations for the treatment of alzheimer's disease
#1221FISH OIL IN STABILIZED FORM
#1222Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof
#1223COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#1224TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS
#1225Antimicrobial compositions
#1226Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#1227COMPOSITION AND METHOD OF TREATING FACIAL SKIN DEFECT
#1228DOG PHEROMONE FORMULATION AND DELIVERY SYSTEM
#1229Fatty acid antimicrobial
#1230Treatment of Huntington's Disease With EPA
#1231Method for Lowering Risk of Cardiovascular Diseases
#1232USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF SMOOTH MUSCLE DISORDERS
#1233Activators of peroxisome proliferator-activated receptors
#1234LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF
#1235METHOD FOR TREATING HEART ATTACKS, STROKES AND DIABETIC CRISIS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT NECESSARY PROTEIN MOLECULES AND VITAL NUTRIENTS INTO TARGETED CELLS
#1236METHODS AND MATERIALS FOR TREATING AND PREVENTING INFLAMMATION OF MUCOSAL TISSUE
#1237Lipid Mixture and Use Thereof in the Preparation of a Product That Is Intended for Enteral or Oral Administration
#1238Esterified fatty acid composition
#1239Dihydroxyl compounds and compositions for cholesterol management and related uses
#1240Low dose lipoic and pharmaceutical compositions and methods
#1241Method for treating inflammation
#1242REELIN DEFICIENCY OR DYSFUNCTION AND METHODS RELATED THERETO
#1243Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#1244USE OF RXR AGONISTS FOR THE TREATMENT OF OSTEOARTHRITIS
#1245THERAPEUTIC AGENT FOR ACUTE CEREBRAL INFARCT
#1246Methods and compositions for the prevention and treatment of inflammatory diseases
#1247TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS
#1248PHARMACEUTICAL COMPOSITION COMPRISING MICROCAPSULES OF STATINS SUSPENDED IN ALKYL ESTERS OF POLYUNSATURATED FATTY ACIDS (PUFA)
#1249Liposomal formulations of hydrophobic lactone drugs in the presence of metal ions
#1250Liposomal Formulations of Hydrophobic Lactone Drugs in the Presence of Metal Ions
#1251Composition and method for treating and preventing musculoskeletal and connective tissue disorders
#1252INHIBITORS OF NITRIC OXIDE SYNTHASE
#1253REDUCED-IRRITANT DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND BENZOYL PEROXIDE AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH
#1254USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID, SPHINGOLIPID AND CHOLESTEROL.
#1255Topical compositions containing solubilized dicarboxylic acids
#1256USE OF AGENTS THAT PREVENT GENERATION OF AMYLOID AND AMYLOID-LIKE LIPOPROTEINS, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT NEUROTOXICITY OF SUCH PROTEINS IN THE TREATMENT OF HEARING LOSS AND IMPROVING BODY BALANCE
#1257Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases
#1258Controlled release polymeric compositions of bone growth promoting compounds
#1259Composition containing higher fatty acid derivative and foods and drinks
#1260Infant nutritional compositions for preventing obesity
#1261Compositions and methods for treating inflammatory conditions
#1262Ignition circuit for igniting a discharge lamp and method for igniting the discharge lamp
#1263PHARMACEUTICAL FOR PROTECTION OF MOTOR NERVE IN PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS
#1264Anticancer agents based on regulation of protein prenylation
#1265Nutritional composition for controlling blood sugar level
#1266Nutrition with lipids and non-digestible saccharides
#1267Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
#1268Lipid compositions for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carinogenesis
#1269Transient receptor potential vanilloid 1 and uses thereof
#1270Cosmetic Compositions Comprising Hydroxyfatty Acids
#1271KIT FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
#1272Eukaryotic Microorganisms for producing lipids and antioxidants
#1273PUFA SUPPLEMENTS
#1274Methods and compounds for treating retinol-related diseases
#1275Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
#1276THERAPEUTIC AGENT FOR OPHTHALMIC DISEASE
#1277Dipeptides for prevention of muscle breakdown and microbial infection
#1278Methods For Reducing The Amount Of A Proinflammatory Substance In Animal Tissue Or Body Fluid
#1279ANTI-PROLIFERATIVE COMBINATIONS
#1280Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
#1281METHOD OF ADMINISTERING OPHTHALMIC FLUIDS
#1282Biologically active oils
#1283Method of alleviating chronic pain via peripheral glutaminase regulation
#1284Novel Statin Pharmaceutical Compositions and Related Methods of Treatment
#1285Method for treatment of onychomycosis
#1286(2R)-2-propyloctanoic acid for functional brain disease
#1287Combinations of vasoprotective agents and formulations containing them
#1288Therapeutic agent for pain
#1289PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds
#1290BRUISE AMELIORATION COMPOSITION AND METHOD OF USE
#1291Novel cochleate formulations
#1292METHODS OF TRANSLATION AND/OR INFLAMMATION BLOCKADE
#1293Multi-step method of pain and/or inflammation treatment
#1294Composition for improving membrane composition and functioning of cells
#1295Methods of Administering 3, 3, 14, 14 Tetramethyl Hexadecane 1, 16 Dioic Acid
#1296STABLE BEVERAGE PRODUCTS COMPRISING POLYUNSATURATED FATTY ACID EMULSIONS
#1297COATED TABLETS, THEIR METHODS OF PREPARATION, AND RELATED USES
#1298Stimulation of an immune response by cationic lipids
#1299Oligomers of straight-chain and unbranched fatty acids and drugs containing these
#1300PHARMACEUTICAL COMBINATION OF NSAID AND PROSTAGLANDIN COMPOUND
#1301UNIT DOSE FORMULATIONS AND METHODS OF TREATING AND PREVENTING THROMBOSIS WITH THROMBOXANE RECEPTOR ANTAGONISTS
#1302USE OF TP MODULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS IN ASPIRIN SENSITIVE AND OTHER POPULATIONS
#1303Antimicrobial and antiviral composition
#1304Spot-on formulation useful for cosmetology and dermatology
#1305Methods of treating ear infections
#1306Antimicrobial and antiviral composition
#1307Compounds to promote regeneration of bone marrow
#1308Composition for improving membrane composition and functioning cells
#1309Compositions Containing A Capillary -Active System With Application -Relevant Differentiability, And The Use Thereof
#1310Therapeutic intervention to MIMIC the effect of caloric restriction
#1311Substances for Reducing Occurence of Major Cardiac Events in Humans
#1312Regulator of Physiological Function of Ghrelin and Use Thereof
#1313COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING CELLS
#1314Composition for improving membrane composition and functioning of cells
#1315Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog
#1316Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders
#1317METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS
#1318Bioeffective krill oil compositions
#1319PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES
#1320Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
#1321Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#1322SUSTAINED RELEASE COMPOSITIONS OF DRUGS
#1323Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract
#1324Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
#1325Compounds to promote regeneration of bone marrow
#1326TREATMENT AND PREVENTION OF EXCESSIVE SCARRING
#1327Gastric Therapies Amd Compositions Therefor
#1328Natural Remedy-Dietary Supplement Combination Product
#1329Foam skin cream, uses of the foam skin protection cream and a process for its preparation
#1330Bio-absorbable oil suspension
#1331VITAMIN C PREPARATION
#1332Orally-absorbed formulation for paromomycin
#1333Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#1334ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#1335Antimicrobial Compositions
#1336Preparation for the prevention and/or treatment of vascular disorders
#1337Cosmetic composition comprising a lipid fraction from vegetable source and anticrystaling agent
#1338Stable Oral Pharmaceutical Composition
#1339Method for treatment of common acne
#1340Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
#1341Fatty acids-systemic lipid solubilizers conjugates
#1342METHOD FOR TREATING INFLAMMATION
#1343Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases
#1344Process for the Heterotrophic Production of Microbial Products with High Concentrations of Omega-3 Highly Unsaturated Fatty Acids
#1345KRILL OIL COMPOSITIONS
#1346Diagnosis and treatment of cancer related to human dormancy
#1347CO-BEADLET OF DHA AND ROSEMARY AND METHODS OF USE
#1348Compositions containing coenzyme Q-10 and dihydrolipoic acid
#1349Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea
#1350Nutrient Sensor
#1351METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES
#1352Activators of peroxisome proliferator-activated receptors
#1353MATRIX-EMBEDDED COMPOSITIONS HAVING ORGANIC ACIDS AND FATTY ACIDS
#1354Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function
#1355Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
#1356Methods of attenuating autoimmune disease and compositions useful therefor
#1357PARTICULATE COMPOSITION COMPRISING BIOACTIVE SUBSTANCE AND METHOD OF PRODUCING THE SAME
#1358Use Of A Fatty Acid For Preparing A Topical Composition For Allaying Inflammatory Reaction Due To Vennemous Hymenoptera Strings
#1359Rapid release mini-tablets provide analgesia in laboratory animals
#1360Composition and method for treating or preventing gastrointestinal cancer
#1361Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides
#1362METHODS AND COMPOSITIONS FOR PROMOTING NORMAL CELL GROWTH AND INHIBITING CANCER CELL GROWTH
#1363STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS
#1364Methods and compositions for activating regenerative stem cells from bone marrow
#1365Meal replacement compositions and weight control method
#1366PROTEOMIC ANTISENSE MOLECULAR SHIELD AND TARGETING
#1367Regulation of Phospholipase D Activity
#1368Lipoxin Analogs as Novel Inhibitors of Angiogenesis
#1369Dihydroxyl compounds and compositions for cholesterol management and related uses
#1370Modulation of Inflammation Related to Columnar Epithelia
#1371STABLE POLYUNSATURATED FATTY ACID EMULSIONS AND METHODS FOR INHIBITING, SUPPRESSING, OR REDUCING DEGRADATION OF POLYUNSATURATED FATTY ACIDS IN AN EMULSION
#1372Cns Modulators
#1373Capsule Stable Against Mastication
#1374Compositions and methods for transient receptor potential vanilloid (TRPV) channel mediated treatments
#1375EQUINE GASTRIC ULCER THERAPY COMPOSITIONS AND EQUINE ULCER MANAGEMENT METHOD
#1376Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors
#1377Cytotropic heterogeneous molecular lipids (CHML), method of preparation, and methods of treating patients with multiple cancers
#1378Use of Cyclodextrin Complexes Containing Lipoic Acid
#1379Barrier Integrity in Hiv Patients
#1380PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
#1381Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
#1382Dopaminergic Mimetics
#1383PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
#1384Method for treatment of onychomycosis
#1385Type A gelatin capsule containing PUFA in free acid form
#1386Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein
#1387Method and composition for treatment of inflammatory conditions
#1388Antimicrobial compositions
#1389Sprayable beautifying composition
#1390SOFTGEL CAPSULES
#1391Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
#1392Alpha2delta ligands for the treatment of fibromyalgia and other disorders
#1393Solid oral dosage form containing an enhancer
#1394BIOCOMPATIBLE TEA TREE OIL COMPOSITIONS
#1395Strontium compound for treatment of sub-dermal soft tissue pain
#1396Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
#1397Compositions and methods for detecting and treating tumors containing acidic areas
#1398Therapy for multiple sclerosis
#1399Medium chain fatty acids applicable as anti-microbial agents
#1400Metronidazole/azelaic acid compositions for the treatment of rosacea
#1401Health bars and compositions for improving cardiovascular risk factors
#1402PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
#1403Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung Diseases
#1404Preparation for the prevention and/or treatment of vascular disorders
#1405Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
#1406Treatment methods requiring phyto-ingredients
#1407COMPOSITIONS OF AN ANTICONVULSANT AND METHODS OF USING THE SAME FOR REVERSING WEIGHT GAIN
#1408Regulation of mammalian keratinous tissue using skin care actives
#1409PUFA supplements
#1410Hydroxyl compounds and compositions for cholesterol management and related uses
#1411Cholestrol-reducing agent containing an n-3 fatty acid
#1412Composition and method for issue repair and regeneration
#1413PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
#1414PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS
#1415Treatment of Huntington's Disease with EPA
#1416Methods of treating hematological malignancies
#1417Agent for enhancing the production of collagen, their preparation and use
#1418Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity
#1419Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements
#1420Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases
#1421Methods and compositions for the treatment of asthma
#1422Drug containing (2R)-2-propyloctanoic acid as the active ingredient
#1423Azithromycin for treatment of granulomatous rosacea
#1424Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid
#1425Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#1426Krill extracts for treatment of cardiovascular diseases
#1427Topical pharmaceutical composition for the treatment of inflammatory dermatoses
#1428Early insulin secretion stimulator
#1429Nutritional composition for wound healing
#1430Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#1431Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient
#1432Activated citrus peel extract
#1433Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
#1434Method for preventing and/or treating neurodegenerative diseases
#1435Nerve regeneration promoters
#1436Blockade of mtor to prevent a hormonal adaptive response
#1437Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions
#1438Aiding of cognitive function
#1439Alpha 2 delta ligands for post-traumatic stress disorder
#1440Inhibitors of nitric oxide synthase to treat type 1 diabetes
#1441Antimicrobial and antiviral composition
#1442Application of asiatic acid and its derivatives to treat pulmonary fibrosis
#1443Method for treating renal disease
#1444Antisense permeation enhancers
#1445Veterinary composition and method of using same
#1446Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
#1447Method for treating inflammation
#1448Reduction of hair growth
#1449Control of biofilm formation
#1450Body temperature elevating agents
#1451Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
#1452Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
#1453Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
#1454Anti-obesity agent
#1455Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
#1456Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
#1457Method for preventing ulceration or irritation of mucosa
#1458Additive for food and beverage, pharmaceutical composition, GLUT4 translocator, and method for translocating GLUT4
#1459Biologically active oils
#1460Fatty alcohols and fatty acid esters useful for treatment of inflammation
#1461Soap scent patch and treatment for muscle spasm and pain
#1462Transdermal patch and treatment for pain and discomfort
#1463Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#1464Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#1465Novel nutraceutical compositions comprising epigallocatechin gallate
#1466Topical Use of Valproic Acid for the Prevention or Treatment of Skin Disorders
#1467Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss
#1468Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#1469Use of an antioxidant in a dermatological and/or cosmetic composition
#1470Use of physiologically active fatty acids
#1471Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ
#1472Inhibition of NF-kappaB by triterpene compositions
#1473Method for treating urushiol induced contact dermatitis
#1474Treatment for severe melancholic depression
#1475Compounds and methods for the treatment or prevention of infections
#1476Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
#1477Composition containing higher fatty acid derivative and foods and drinks
#1478Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
#1479Anticancer agents based on regulation of protein prenylation
#14805,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
#1481Compositions and dosage forms for enhanced absorption
#1482Method for treating bacterial infections in horses or pigs with tilmicosin
#1483Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
#1484Activators of peroxisome proliferator-activated receptors
#1485Composition and method for treating skin conditions
#1486Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease
#1487Method
#1488Fatty acid-containing compositions and methods for the treatment of cytokine mediated disorders
#1489Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress
#1490Antiseptic compositions and methods of use
#1491Statin pharmaceutical compositions and related methods of treatment
#1492Medicine for prevention or treatment of diabetes
#1493Foam skin cream, use of the foam skin protection cream and a process of its preparation
#1494Lipoxin analogs as novel inhibitors of angiogenesis
#1495Intraluminal device with a coating containing a therapeutic agent
#1496Glycogen or polysaccharide storage disease treatment method
#1497Topical pharmaceutical composition to treat hyperpigmentation of the skin
#1498Abuse-deterrent drug formulations
#1499Topical compositions and methods for epithelial-related conditions
#1500Medicine for prevention or treatment of diabetes